
The conversation centers on the emerging gut‑muscle axis and how excessive protein intake can backfire when the gastrointestinal environment is compromised. Dr. Tom Fabian explains that while protein is essential for muscle synthesis, its benefits are mediated by gut‑derived T‑reg cells and short‑chain fatty acids, which depend on a healthy microbiome and efficient digestion. Key insights include the pivotal role of stomach acid and pancreatic enzymes in breaking down amino acids; conditions such as H. pylori‑induced hypochlorhydria, age‑related enzyme decline, and dysbiosis can blunt protein absorption and even promote food sensitivities. Functional stool panels like the GIM‑Map provide direct markers (e.g., elastase) and indirect clues (commensal overgrowth) to assess digestive capacity before escalating protein. Fabian cites clinical thresholds—protein up to 2.2 g/kg body weight is common, yet patients often exceed this without adequate fiber or polyphenols, leading to microbial overgrowth. He highlights that elastase values below 100 suggest pancreatic insufficiency, while sub‑optimal ranges (200‑500) warrant intervention, and that elevated opportunistic bacteria signal low acid environments. For practitioners, the takeaway is clear: evaluate gut health with functional testing, address hypochlorhydria or enzyme deficits, and tailor protein sources to each patient’s digestive profile. This personalized approach maximizes muscle benefits while minimizing inflammation, allergies, and microbiome disruption.

The presentation focused on an evidence‑based omega‑3 protocol designed to improve cardiovascular health, cognitive function, and overall longevity. Drawing from decades of research, the speaker highlighted how omega‑3 fatty acids—particularly EPA and DHA—interact with vitamin D and resistance training to decelerate...

The video explores how evolutionary biology and animal models—particularly companion‑animal gene therapy and hibernation physiology—are being leveraged to accelerate longevity research for humans. Rejuvenate Bio is testing AAV‑based gene therapies in dogs, reporting restored cardiac function, delayed renal decline, and improved...

Dr. Mary Claire Haver, a board‑certified OB‑GYN and menopause specialist, frames perimenopause as a "zone of chaos" where the brain’s hormonal feedback loop breaks down, leading to brain fog, anxiety, and sleep disruption before any noticeable changes in menstrual cycles. She...

Longevity clinics are emerging as a distinct medical niche, with high‑end facilities and hospital affiliates rebranding under a longevity framework. The segment ranges from rigorously protocol‑driven centers that integrate diagnostics and longitudinal follow‑up to aesthetic and hormone‑focused practices that adopt...

The video discusses a July 2025 study from Korea University of Medicine that pinpointed the protein HMGB1 as a key circulating factor that accelerates aging when transferred via blood. Building on classic parabiosis experiments—young mice rejuvenated by old blood and vice‑versa—the...

Rhonda Patrick revisits her sauna recommendations, emphasizing that a traditional hot sauna—around 175 °F—remains the gold standard for cardiovascular and brain health. She contrasts this with infrared saunas, noting that comparable benefits require substantially longer sessions, making the hot sauna more efficient...

Berlin‑based Celicks announced a $10 million financing round aimed at accelerating its proprietary 3D bioprinting platform for vascularized tissue implants. The capital will fund the transition of its lead programs from pre‑clinical studies into early‑stage clinical trials, positioning the startup at...

Eli Lilly is quietly reshaping its R&D agenda, moving from a narrow GLP‑1 obesity play toward a broader longevity strategy. The company’s recent moves signal an ambition to become a “big farmer” of age‑related therapeutics, even if the term does not...

The video reframes beta‑alanine from a fleeting pre‑workout tingling agent to a daily supplement that raises muscle carnosine and influences multiple physiological systems. Carnosine neutralizes reactive carbonyl compounds such as methylglyoxal, which otherwise impair insulin signaling, leading to measurable improvements in...

Premas, a neuro‑tech firm, has announced a partnership with Health is One to roll out its early‑brain‑screening platform across the health‑system network. The initiative focuses on detecting neurodegenerative disease risk factors before patients exhibit any clinical signs. The screening leverages proprietary...

The video centers on how a single night of poor sleep can impair the brain’s waste‑clearance system, and Dr. Majid Fotuhi explains practical steps to safeguard that process. He links stress‑induced insomnia to hippocampal damage, emphasizing that mental rumination is often...

The video centers on glutathione – the liver’s primary antioxidant – and its pivotal role in preventing non‑alcoholic fatty liver disease (NAFLD) and insulin resistance. It argues that glutathione loss is not just a symptom of metabolic dysfunction but a...

The Longevity Biomarker Summit panel brought together policy leader Tina Woods, Buck Institute CEO Eric Verden, translational scientist Jasmine Smith, and Disney‑affiliated researcher Keith Kido to debate whether the field is asking the wrong question—healthspan versus lifespan. The speakers converged on...